Clinical trial
An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.
NCT02250482 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.
- Lead sponsor
- Bio Products Laboratory
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2001
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
haemophilia a